Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Jan
13
2021
American Axle & Manufacturing v. Neapco Holdings–Part II Schwegman, Lundberg & Woessner, P.A.
Jan
12
2021
Innovation to Production: 4 Strategies to Protect IP When Collaborating Vedder Price
Jan
11
2021
American Axle Petitions for Cert. Schwegman, Lundberg & Woessner, P.A.
Jan
7
2021
The Jury Returns…Returns. McDermott Will & Schulte LLP
Jan
7
2021
Government Contractors May Include Restrictive Markings on ‘Unlimited Rights’ Data McDermott Will & Schulte LLP
Jan
1
2021
Federal Circuit Endorses the Doctrine of Equivalents Again for Lilly’s ALIMTA®: Different Amendment, Same Result Squire Patton Boggs (US) LLP
Dec
30
2020
Arthrex’s Initial Merits Brief – Making the Case for Patent Judges as Principal Officers Foley & Lardner LLP
Dec
21
2020
Restrictions on Venue in Hatch-Waxman Litigation Epstein Becker & Green, P.C.
Dec
17
2020
US Courts Can Compel Parties to Transfer Ownership of Foreign Patents McDermott Will & Schulte LLP
Dec
15
2020
Employment Law and Patent Law Collide: Federal Circuit Rules that California’s Non-Compete Restrictions Also Limit the Scope of Patent and Invention Assignment Clauses Hunton Andrews Kurth
Dec
10
2020
Reprints Do Not Change Earlier Publication Date McDermott Will & Schulte LLP
Dec
4
2020
The Wide-Ranging Effects of the Federal Circuit’s Assault on Skinny Labels Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
4
2020
IP Litigation Quarterly Update: Q3 2020 Miller Canfield
Dec
3
2020
Apportionment Unnecessary When Royalty Is Based on Comparable License McDermott Will & Schulte LLP
Dec
3
2020
Making Waves: Post-Employment Contract Assignment Provision Invalid Under California Law McDermott Will & Schulte LLP
Nov
30
2020
Federal Circuit Clarifies The “Reasonably Pertintent” Analogous Art Standard Foley & Lardner LLP
Nov
30
2020
Vectura v. GlaxoSmithKline – How to Keep Process Limitations out of Composition Claims Schwegman, Lundberg & Woessner, P.A.
Nov
24
2020
Covered Business Method Threshold Review Is Not Appealable McDermott Will & Schulte LLP
Nov
24
2020
Wave Goodbye to Lost Arguments: Waiver Versus Forfeiture Law McDermott Will & Schulte LLP
Nov
24
2020
Divided (Induced, Contributory) Patent Infringement—“Follow the Product” Summa PLLC
Nov
21
2020
In Hatch-Waxman litigation, Federal Circuit restricts venue under the TC Heartland to districts relating to ANDA filings Mintz
Nov
19
2020
Transfer Motions Must Take Top Priority McDermott Will & Schulte LLP
Nov
19
2020
No Patent? No Problem! The Federal Circuit Paves The Way For Non-Patent Owners To Sue Infringers Vedder Price
Nov
19
2020
Analogous Art Includes Reference a Skilled Artisan Would Reasonably Consult McDermott Will & Schulte LLP
Nov
19
2020
Printed Matter Is Patentable If It’s Functional, Not Just Communicative McDermott Will & Schulte LLP
Nov
19
2020
Summary Judgment Foreclosed when There Is More than One Possible Inference from Evidence McDermott Will & Schulte LLP
Nov
18
2020
Rise of the Improper Markush Grouping Rejection and Biomolecules Mintz
Nov
17
2020
Prosecution Guidance from the Fed. Cir. – How to Forfeit Arguments During Your Appeal Schwegman, Lundberg & Woessner, P.A.
Nov
13
2020
C. R. Bard v. Angiodynamics – It’s a Labelled Injection Port, not a Label Schwegman, Lundberg & Woessner, P.A.
Nov
11
2020
Federal Circuit Will Not Second-Guess IPR Institution Denials McDermott Will & Schulte LLP
Nov
11
2020
Venue in Hatch-Waxman Cases Limited to District Where ANDA Is Submitted McDermott Will & Schulte LLP
Nov
10
2020
Federal Circuit Limits Venue In ANDA Litigation Foley & Lardner LLP
Nov
9
2020
Immunex v. Sanofi-Aventis – The “Mystery Dance” of Claim Construction Schwegman, Lundberg & Woessner, P.A.
Nov
6
2020
Federal Circuit Limits Venue for Hatch-Waxman Cases Polsinelli PC
Nov
4
2020
Too Good to Be True? Federal Circuit Demands Evidence of Reliance on Favorable Ruling, Stipulation McDermott Will & Schulte LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters